Opens in a new tab Opens in a new tab Opens in a new tab
Opens in a new tab Opens in a new tab Opens in a new tab

More News

| March 13, 2025

Key Takeaways from Leading Global Industry Gatherings in 2025

The big picture: Spiderwort Biotechnologies hit the road in the first six weeks of the year to showcase our CelluBridge® and CelluJuve® biomaterial innovation at five global events in the United States, France, and Canada.

By the numbers:

  • 23,000+ total attendees
  • 5 shows
  • 3 countries

Why it matters: This event series brought Spiderwort Biotechnologie’s innovative approach in front of key decision makers, investors, and partners across the broader biotechnology, health science, and medical aesthetics industries.

Highlights:

  • For Octane and IMCAS:
    • CelluJuve®‘s unique approach to addressing the legacy dermal filler market
    • Pre-clinical study results
    • Physician feedback on potential applications
  • For Biotech Showcase 2025:
    • CelluBridge®‘s potential to improve quality of life
  • For 2025 OBIO Investment Summit:
    • Sharing Spiderwort Biotechnologies’ journey as a Canadian innovation success story
    • Biomaterial technology applications
  • For BIO CEO & Investor Conference:
    • Introducing Spiderwort Biotechnologies capabilities with a broad network of institutional investors focused on private biotech companies
    • Focused on accelerating the development of therapies

Market insights:

  • Increasingly diverse consumer base in medical aesthetics via McKinsey
  • Spinal cord injury patient needs via NICHD align with our development path

The bottom line: Octane, Biotech Showcase, IMCAS World Congress, OBIO Investment Summit, and the BIO CEO & Investor Conference reinforced our mission to bring new solutions to solve unmet needs in the medical community. 

What’s next:

Hear More From Us